SNDL SNDL Inc.

Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing ACB’s leadership across global medical markets. Adjusted gross margin reached 58%, […] The post Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests

Key Takeaways; Cannabis Sector Vireo Growth to Acquire Planet 13 in Landmark All-Stock Deal SNDL Completed Parallel Asset Acquisition, Expanding its U.S. Medical Cannabis Footprint Tilray Posted Record FY2026 Revenue as Cannabis Sales Rose and Losses Narrowed Key Takeaways; Psychedelic Sector Eli Lilly’s $3.8 Billion Deal to Acquire AtaiBeckley Signals a Major Push into Psychedelic-Inspired […]

SNDL sinks after weak Q2 2026 earnings, but can cost cuts and U.S. expansion through Parallel offset ongoing cannabis and liquor headwinds?

SNDL Inc (SNDL) showcases financial resilience with strategic share repurchases and a debt-free balance sheet, despite facing revenue and margin pressures.

SNDL (NASDAQ:SNDL) reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on results. The company said it continued to generate positive operating cash flow and improved free cas

SNDL INC (SNDL) delivered earnings and revenue surprises of -100.00% and -1.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?